Comparing Genome Selection to Drug Interventions

Noor Siddiqui is the founder of Orchid, which offers whole genome screening for over 1,000 genetic diseases. We cover the transition from biological chance to choice, American public support for embryo screening, the historical stigma against routine procedures like heart transplants, and the new political divide of Primitivism versus Futurism. If you're interested in these ideas, you might be interested in Network School. Apply online at https://ns.com.